Literature DB >> 10591737

Effectiveness of glucocorticoids in treating croup. Authors acknowledge Cochrane Collaboration.

T P Klassen.   

Abstract

Mesh：

Substances：

Year:  1999        PMID： 10591737      PMCID： PMC1117282          DOI： 10.1136/bmj.319.7224.1577a

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  6 in total

Review 1.  Management of childhood croup.

Authors:  W B Macdonald; G C Geelhoed
Journal:  Thorax       Date:  1997-09       Impact factor: 9.139

2.  Double blind placebo controlled trial of nebulised budesonide for croup.

Authors:  C W Godden; M J Campbell; M Hussey; J J Cogswell
Journal:  Arch Dis Child       Date:  1997-02       Impact factor: 3.791

3.  The effectiveness of glucocorticoids in treating croup: meta-analysis.

Authors:  M Ausejo; A Saenz; B Pham; J D Kellner; D W Johnson; D Moher; T P Klassen
Journal:  BMJ       Date:  1999-09-04

4.  Nebulized budesonide for children with mild-to-moderate croup.

Authors:  T P Klassen; M E Feldman; L K Watters; T Sutcliffe; P C Rowe
Journal:  N Engl J Med       Date:  1994-08-04       Impact factor: 91.245

5.  Efficacy of a small single dose of oral dexamethasone for outpatient croup: a double blind placebo controlled clinical trial.

Authors:  G C Geelhoed; J Turner; W B Macdonald
Journal:  BMJ       Date:  1996-07-20

6.  Use of dexamethasone in the outpatient management of acute laryngotracheitis.

Authors:  M N Cruz; G Stewart; N Rosenberg
Journal:  Pediatrics       Date:  1995-08       Impact factor: 7.124
  6 in total
  2 in total

1.  Inpatient use of racemic epinephrine for children admitted with croup.

Authors:  Elaine Chiang; Omar Afandi; Sang Hoon Lee; Srinivasan Suresh; Raymond D Pitetti; Sriram Ramgopal
Journal:  World J Pediatr       Date:  2019-07-25       Impact factor: 2.764

2.  A retrospective population based trend analysis on hospital admissions for lower respiratory illness among Swedish children from 1987 to 2000.

Authors:  Ove Björ; Lennart Bråbäck
Journal:  BMC Public Health       Date:  2003-07-11       Impact factor: 3.295
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.